Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ibrahim Yakoub-Agha, MD, PhD, Lille University Hospital, Lille, France, shares the key themes that will be addressed during the 3rd edition of the European CAR T-cell Meeting. The program will cover all aspects of CAR T-cell therapy, from translational research to trial results and patient management. Additionally, the meeting will showcase the latest news in CAR T-cell from around the world, including updates from China and the US. This interview took place during the 3rd European CAR T-cell Meeting.
Disclosures
IYA received honorarium from Novartis. He is currently chair of the chronic malignancies working party of EBMT.